Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-06-29 OABI / OmniAb, Inc. 4 Avista Capital Managing Member V, LLC See Notes F - Taxes I 3.75 -59,557
2024-06-28 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 60.62 409
2024-06-28 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 60.62 399
2024-06-28 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 537
2024-06-28 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 537
2024-06-27 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.990 -10,000
2024-06-27 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.68 18,644
2024-06-27 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.75 41,015
2024-06-27 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 4,956
2024-06-27 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 1.641 5,044
2024-06-20 MXCT / MaxCyte, Inc. 4 Ross Thomas M. S - Sale D 4.094 -33,333
2024-06-20 MXCT / MaxCyte, Inc. 4 Ross Thomas M. M - Exercise D 1.641 33,333
2024-06-18 OABI / OmniAb, Inc. 4 Cochran Jennifer R. M - Exercise D 20,000
2024-06-18 OABI / OmniAb, Inc. 4 Bertozzi Carolyn R M - Exercise D 20,000
2024-06-18 OABI / OmniAb, Inc. 4 Boyce Sarah M - Exercise D 20,000
2024-06-18 OABI / OmniAb, Inc. 4 Avista Capital Managing Member V, LLC See Notes M - Exercise I 20,000
2024-06-18 OABI / OmniAb, Inc. 4 HIGGINS JOHN L M - Exercise D 20,000
2024-06-13 ABSI / Absci Corporation 4 Jonasson Zachariah S - Sale D 4.9797 -19,859
2024-06-13 ABSI / Absci Corporation 4 Jonasson Zachariah M - Exercise D 3.39 28,700
2024-06-12 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 60 -19,164
2024-06-12 INCY / Incyte Corporation 4 Schaffert Susanne F - Taxes D 59.94 -752
2024-06-12 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes D - Sale to Issuer I 60.00 -5,283,206
2024-06-12 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes D - Sale to Issuer I 60.00 -175,977
2024-06-12 INCY / Incyte Corporation 4 BIENAIME JEAN JACQUES A - Award D 2,830
2024-06-12 ABSI / Absci Corporation 4 MCGINNIS KAREN K A - Award D 8,820
2024-06-12 ABSI / Absci Corporation 4 Pangalos Menelas N A - Award D 3,675
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 Platt Jamie A - Award D 8,296
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 GIRGENTI STEVEN A - Award D 8,296
2024-06-12 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 2,830
2024-06-12 ABSI / Absci Corporation 4 Sirosh Joseph A - Award D 8,820
2024-06-12 ABSI / Absci Corporation 4 Rabinovitsj Daniel A A - Award D 8,820
2024-06-12 ABSI / Absci Corporation 4 Redmile Group, LLC See Footnotes A - Award I 8,820
2024-06-12 ABSI / Absci Corporation 4 Houten Frans Van A - Award D 8,820
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 KNIGHT PETER S A - Award D 8,296
2024-06-12 INCY / Incyte Corporation 4 FOUSE JACQUALYN A A - Award D 2,830
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 Joyce Roby A - Award D 8,296
2024-06-12 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 2,830
2024-06-12 INCY / Incyte Corporation 4 High Katherine A A - Award D 2,830
2024-06-12 INCY / Incyte Corporation 4 BRAWLEY OTIS W A - Award D 2,830
2024-06-12 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 2,830
2024-06-12 INCY / Incyte Corporation 4 Schaffert Susanne A - Award D 2,830
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 DIAMOND STUART A - Award D 8,296
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 Zannes Maria A - Award D 8,296
2024-06-12 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 2,830
2024-06-12 ABSI / Absci Corporation 4 Nagpal Amrit A - Award D 8,820
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 Rubin Gary D A - Award D 8,296
2024-06-12 BIAF / bioAffinity Technologies, Inc. 4 Anderson Robert A. A - Award D 8,296
2024-06-11 MXCT / MaxCyte, Inc. 4 Hemrajani Rekha A - Award D 21,367
2024-06-11 MXCT / MaxCyte, Inc. 4 BALTHROP PATRICK J A - Award D 21,367
2024-06-11 MXCT / MaxCyte, Inc. 4 Johnston John Joseph A - Award D 21,367
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)